200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 546-88-3

546-88-3

546-88-3 | N-hydroxyacetamide

CAS No: 546-88-3 Catalog No: AG0038NO MDL No:MFCD00009994

Product Description

Catalog Number:
AG0038NO
Chemical Name:
N-hydroxyacetamide
CAS Number:
546-88-3
Molecular Formula:
C2H5NO2
Molecular Weight:
75.0666
MDL Number:
MFCD00009994
IUPAC Name:
N-hydroxyacetamide
InChI:
InChI=1S/C2H5NO2/c1-2(4)3-5/h5H,1H3,(H,3,4)
InChI Key:
RRUDCFGSUDOHDG-UHFFFAOYSA-N
SMILES:
CC(=O)NO
EC Number:
208-913-8
UNII:
4RZ82L2GY5

Properties

Complexity:
42.9  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
75.032g/mol
Formal Charge:
0
Heavy Atom Count:
5  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
75.067g/mol
Monoisotopic Mass:
75.032g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
49.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.6  

Literature

Title Journal
Growth-inhibiting, bactericidal, and urease inhibitory effects of Paeonia lactiflora root constituents and related compounds on antibiotic-susceptible and -resistant strains of Helicobacter pylori. Journal of agricultural and food chemistry 20120912
Characterization of cobalt(III) hydroxamic acid complexes based on a tris(2-pyridylmethyl)amine scaffold: reactivity toward cysteine methyl ester. Inorganic chemistry 20120903
Amelioration of metal-induced toxicity in Caenorhabditis elegans: utility of chelating agents in the bioremediation of metals. Toxicological sciences : an official journal of the Society of Toxicology 20120901
Synthesis, biological evaluation, and molecular docking studies of 2,5-substituted-1,4-benzoquinone as novel urease inhibitors. Bioorganic & medicinal chemistry 20120815
Simple pseudo-dipeptides with a P2' glutamate: a novel inhibitor family of matrix metalloproteases and other metzincins. The Journal of biological chemistry 20120803
Synthesis, inhibitory activity and molecular docking studies of two Cu(II) complexes against Helicobacter pylori urease. Journal of enzyme inhibition and medicinal chemistry 20120801
Studies of histidine residues in soybean (Glycine max) urease. Protein and peptide letters 20120601
N-substituted aminomethanephosphonic and aminomethane-P-methylphosphinic acids as inhibitors of ureases. Amino acids 20120501
The physiological implications of urease inhibitors on N metabolism during germination of Pisum sativum and Spinacea oleracea seeds. Journal of plant physiology 20120501
Modulation of Wnt/β-catenin signaling and proliferation by a ferrous iron chelator with therapeutic efficacy in genetically engineered mouse models of cancer. Oncogene 20120112
Enhanced Bioavailability and Dissolution of Atorvastatin Calcium from Floating Microcapsules using Minimum Additives. Scientia pharmaceutica 20120101
Chitosan-alginate microcapsules of amoxicillin for gastric stability and mucoadhesion. Journal of advanced pharmaceutical technology & research 20120101
Allosteric effects of sulfonate anions on the rates of iron release from serum transferrin. Journal of inorganic biochemistry 20110901
Bis(acetohydroxamato-κO,O')diphenyl-tin(IV). Acta crystallographica. Section E, Structure reports online 20110801
Novel lipophilic acetohydroxamic acid derivatives based on conformationally constrained spiro carbocyclic 2,6-diketopiperazine scaffolds with potent trypanocidal activity. Journal of medicinal chemistry 20110728
Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review. Expert opinion on therapeutic patents 20110601
An improved bioprocess for synthesis of acetohydroxamic acid using DTT (dithiothreitol) treated resting cells of Bacillus sp. APB-6. Bioresource technology 20110601
One-electron oxidation of acetohydroxamic acid: the intermediacy of nitroxyl and peroxynitrite. The journal of physical chemistry. A 20110414
Identifying chelators for metalloprotein inhibitors using a fragment-based approach. Journal of medicinal chemistry 20110127
Structural and functional role of nickel ions in urease by molecular dynamics simulation. Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20110101
Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for h. Pylori. Scientia pharmaceutica 20110101
The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors. European journal of medicinal chemistry 20101101
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Synthesis, molecular docking and biological evaluation of Schiff base transition metal complexes as potential urease inhibitors. European journal of medicinal chemistry 20101001
Computer-aided optimization of phosphinic inhibitors of bacterial ureases. Journal of medicinal chemistry 20100812
Synthesis, structures, and urease inhibitory activities of three copper(II) and zinc(II) complexes with 2-{[2-(2-hydroxyethylamino)ethylimino]methyl}-4-nitrophenol. European journal of medicinal chemistry 20100701
Entropic contribution to the linking coefficient in fragment based drug design: a case study. Journal of medicinal chemistry 20100527
X-ray absorption spectroscopy of aqueous aluminum-organic complexes. The journal of physical chemistry. A 20100527
Inhibitors of human histone deacetylase: synthesis and enzyme assay of hydroxamates with piperazine linker. Archiv der Pharmazie 20100301
13[C]-urea breath test as a novel point-of-care biomarker for tuberculosis treatment and diagnosis. PloS one 20100101
Redox reactions of Pu(IV) and Pu(III) in the presence of acetohydroxamic acid in HNO(3) solutions. Inorganic chemistry 20091221
The interaction of zinc(II) and hydroxamic acids and a metal-triggered Lossen rearrangement. Chemistry (Weinheim an der Bergstrasse, Germany) 20091214
Lipoamide dehydrogenase and diaphorase catalyzed conversion of some NO donors to NO and reduction of NO scavenger 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (PTIO). General physiology and biophysics 20091201
Inhibitors of bacterial N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) and demonstration of in vitro antimicrobial activity. Bioorganic & medicinal chemistry letters 20091115
Medical treatment of pediatric urolithiasis. Pediatric nephrology (Berlin, Germany) 20091101
Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors. Bioorganic & medicinal chemistry 20091101
Hydroxamic acids as a novel family of serine racemase inhibitors: mechanistic analysis reveals different modes of interaction with the pyridoxal-5'-phosphate cofactor. Journal of medicinal chemistry 20091008
Amines and oximes derived from deoxybenzoins as Helicobacter pylori urease inhibitors. European journal of medicinal chemistry 20090501
Adsorption of hydroxamate siderophores and EDTA on goethite in the presence of the surfactant sodium dodecyl sulfate. Geochemical transactions 20090101
Heart protection by ischemic preconditioning: a novel pathway initiated by iron and mediated by ferritin. Journal of molecular and cellular cardiology 20081201
Design, synthesis, and evaluation of novel organophosphorus inhibitors of bacterial ureases. Journal of medicinal chemistry 20080925
Extended triple-bridged Ni(II)- and Co(II)-hydroxamate trinuclear complexes: synthesis, crystal structures, and magnetic properties. Inorganic chemistry 20080804
Reduction of pertechnetate by acetohydroxamic acid: formation of [TcII(NO)(AHA)2(H2O)]+ and implications for the UREX process. Inorganic chemistry 20080804
Chelated iron sources are inhibitors of Pseudomonas aeruginosa biofilms and distribute efficiently in an in vitro model of drug delivery to the human lung. Journal of applied microbiology 20080801
Immobilised metal affinity chromatography for the capture of hydroxamate-containing siderophores and other Fe(III)-binding metabolites directly from bacterial culture supernatants. The Analyst 20080701
Floating in situ gelling system of acetohydroxamic acid for clearance of H. pylori. Drug development and industrial pharmacy 20080601
Enzymatic, immunological and phylogenetic characterization of Brucella suis urease. BMC microbiology 20080101
Vasorelaxant activity of some oxime derivatives. European journal of pharmacology 20071201
Preparation and in vitro characterization of gellan based floating beads of acetohydroxamic acid for eradication of H. pylori. Acta pharmaceutica (Zagreb, Croatia) 20071201
Jack bean urease: the effect of active-site binding inhibitors on the reactivity of enzyme thiol groups. Bioorganic chemistry 20071001
A membrane associated metalloprotease cleaves Cry3Aa Bacillus thuringiensis toxin reducing pore formation in Colorado potato beetle brush border membrane vesicles. Biochimica et biophysica acta 20070901
Design of novel histone deacetylase inhibitors. Bioorganic & medicinal chemistry letters 20070815
Benzo[b]thiophene-based histone deacetylase inhibitors. Bioorganic & medicinal chemistry letters 20070815
Spectroscopic study of the uranyl-acetohydroxamate adduct with tributyl phosphate. Applied spectroscopy 20070701
Polyphenols based on isoflavones as inhibitors of Helicobacter pylori urease. Bioorganic & medicinal chemistry 20070601
Exploring the subtleties of drug-receptor interactions: the case of matrix metalloproteinases. Journal of the American Chemical Society 20070307
Laccase induction in fungi and laccase/N-OH mediator systems applied in paper mill effluent. Bioresource technology 20070101
Simultaneous Determination of Cobalt(II) and Nickel(II) by Fourth-Order Derivative Spectrophotometric Method Using 2-Hydroxy-3-Methoxy Benzaldehyde Thiosemicarbazone. Journal of automated methods & management in chemistry 20070101
Interaction of imidazole containing hydroxamic acids with Fe(III): hydroxamate versus imidazole coordination of the ligands. Bioinorganic chemistry and applications 20070101
Bioactive oligostilbenoids from the stem bark of Hopea exalata. Journal of natural products 20061201
Infrared spectroscopic studies of siderophore-related hydroxamic acid ligands adsorbed on titanium dioxide. Langmuir : the ACS journal of surfaces and colloids 20061121
Synthesis of bicyclic molecular scaffolds (BTAa): an investigation towards new selective MMP-12 inhibitors. Bioorganic & medicinal chemistry 20061115
Near edge X-ray absorption fine structure spectroscopy of bacterial hydroxamate siderophores in aqueous solutions. The journal of physical chemistry. A 20061026
Floating hot-melt extruded tablets for gastroretentive controlled drug release system. Journal of controlled release : official journal of the Controlled Release Society 20061010
N-hydroxyurea--a versatile zinc binding function in the design of metalloenzyme inhibitors. Bioorganic & medicinal chemistry letters 20060815
Di-, tri-, and tetranuclear zinc hydroxamate complexes as structural models for the inhibition of zinc hydrolases by hydroxamic acids. Inorganic chemistry 20060529
Synthesis and antibacterial activity of novel oxazolidinones bearing N-hydroxyacetamidine substituent. Bioorganic & medicinal chemistry letters 20060501
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Towards third generation matrix metalloproteinase inhibitors for cancer therapy. British journal of cancer 20060410
A new role for old ligands: discerning chelators for zinc metalloproteinases. Journal of the American Chemical Society 20060315
Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivity. Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20060301
Alcohol and oxidative liver injury. Hepatology (Baltimore, Md.) 20060201
Characterization and optimization of experimental variables within a reproducible bladder encrustation model and in vitro evaluation of the efficacy of urease inhibitors for the prevention of medical device-related encrustation. Journal of biomedical materials research. Part B, Applied biomaterials 20060101
Pb(II)-binding capability of aminohydroxamic acids: primary hydroxamic acid derivatives of alpha-amino acids as possible sequestering agents for Pb(II). Journal of inorganic biochemistry 20060101
Hard and soft X-ray absorption spectroscopic investigation of aqueous Fe(III)-hydroxamate siderophore complexes. The journal of physical chemistry. A 20051117
Application of Fourier transform infrared spectroscopy for monitoring hydrolysis and synthesis reactions catalyzed by a recombinant amidase. Analytical biochemistry 20051101
Chemistry of a Ni(II) acetohydroxamic acid complex: formation, reactivity with water, and attempted preparation of zinc and cobalt analogues. Inorganic chemistry 20051003
DFT study of the V(IV)/V(V) oxidation mechanism in the presence of N-hydroxyacetamide. Journal of inorganic biochemistry 20050801
Dimerization of the keto tautomer of acetohydroxamic acid-infrared matrix isolation and theoretical study. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20050501
Release of iron from ferritin by aceto- and benzohydroxamic acids. Inorganic chemistry 20050418
Neutral acetohydroxamic acid coordination to a mononuclear Ni(II) center stabilized by an intramolecular hydrogen-bonding interaction. Chemical communications (Cambridge, England) 20050128
Ternary ligand-zinc-hydroxamate complexes. Inorganic chemistry 20050110
Urease-induced alkalinization of extracellular pH and its antitumor activity in human breast and lung cancers. Journal of experimental therapeutics & oncology 20050101
Pyrazolylborate-zinc alkoxide complexes. 3. Acid-base reactions. Inorganic chemistry 20040920
Receptor-mediated targeting of lipobeads bearing acetohydroxamic acid for eradication of Helicobacter pylori. Journal of controlled release : official journal of the Controlled Release Society 20040914
Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12. Journal of molecular biology 20040820
Mechanism of metal-mediated DNA damage induced by a metabolite of carcinogenic acetamide. Chemico-biological interactions 20040810
Acetohydroxamate inhibition of the activity of urease from dehusked seeds of water melon (Citrullus vulgaris). Journal of enzyme inhibition and medicinal chemistry 20040801
New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups. Journal of the American Chemical Society 20040714
Synthesis, antiprotozoal and cytotoxic activities of new N-(3,4-dimethyl-5-isoxazolyl)-1,2-naphthoquinone-4-amino derivatives. Farmaco (Societa chimica italiana : 1989) 20040601
Soybean cultivars 'Williams 82' and 'Maple Arrow' produce both urea and ammonia during ureide degradation. Journal of experimental botany 20040401
Jackbean, soybean and Bacillus pasteurii ureases: biological effects unrelated to ureolytic activity. European journal of biochemistry 20040401
Relaxant effect of oxime derivatives in isolated rat aorta: role of nitric oxide (NO) formation in smooth muscle. Biochemical pharmacology 20040315
Predominant role of basicity of leaving group in alpha-effect for nucleophilic ester cleavage. Bioorganic chemistry 20040201
Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori. The Journal of pharmacy and pharmacology 20031201
First row divalent transition metal complexes of aryl-appended tris((pyridyl)methyl)amine ligands: syntheses, structures, electrochemistry, and hydroxamate binding properties. Inorganic chemistry 20031117
Deprotonation sites of acetohydroxamic acid isomers. A theoretical and experimental study. The Journal of organic chemistry 20030822
Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of Helicobacter pylori. Journal of drug targeting 20030801
Kinetics and mechanism of iron(III)-nitrilotriacetate complex reactions with phosphate and acetohydroxamic acid. Inorganic chemistry 20030630
Potentiometric, spectrophotometric and density functional study of the interaction of N-hydroxyacetamide with oxovanadium(IV): the influence of ligand to the V(IV)/V(V) oxi-reduction reaction. Journal of inorganic biochemistry 20030501
Catalysis of the beta-elimination of HF from isomeric 2-fluoroethylpyridines and 1-methyl-2-fluoroethylpyridinium salts. Proton-activating factors and methyl-activating factors as a mechanistic test to distinguish between concerted E2 and E1cb irreversible mechanisms. The Journal of organic chemistry 20030207
A new approach in gastroretentive drug delivery system using cholestyramine. Drug delivery 20030101
[Antimicrobial action of ammonium salts of fused heterocycles containing ortho-nitrogen]. Medicina (Kaunas, Lithuania) 20030101
NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability. Journal of medicinal chemistry 20021219
Elucidating drug-metalloprotein interactions with tris(pyrazolyl)borate model complexes. Inorganic chemistry 20021007
Design and synthesis of novel inhibitors of gelatinase B. Bioorganic & medicinal chemistry letters 20020819
Dianionic complexes with hexacoordinate silicon(IV) or germanium(IV) and three bidentate ligands of the hydroximato(2-) type: syntheses and structural characterization in the solid state. Inorganic chemistry 20020729
A novel general route for the preparation of enantiopure imidazolines. The Journal of organic chemistry 20020531
Formation and structure of 1:1 complexes between aryl hydroxamic acids and vanadate at neutral pH. Inorganic chemistry 20020520
Acetamidoquinone and acetamidohydroxy derivatives as inhibitors for both dihydroxyacetamido epoxidase and dehydrogenase. Bioorganic & medicinal chemistry 20020501
Thermodynamics, kinetics, and mechanism of the stepwise dissociation and formation of Tris(L-lysinehydroxamato)iron(III) in aqueous acid. Inorganic chemistry 20020325
Urease activity in microbiologically-induced calcite precipitation. Journal of biotechnology 20020214
Purification and characterization of urease isolated from the pathogenic fungus Coccidioides immitis. Medical mycology 20020201
Suppression of Helicobacter pylori-induced gastritis by urease inhibitors in Mongolian gerbils. Gan to kagaku ryoho. Cancer & chemotherapy 20020201
Kinetics of inhibition and molecular asymmetry in pigeonpea (Cajanus cajan) urease. Journal of biochemistry, molecular biology, and biophysics : JBMBB : the official journal of the Federation of Asian and Oceanian Biochemists and Molecular Biologists (FAOBMB) 20020201
Inhibition of bacteriophage lambda protein phosphatase by organic and oxoanion inhibitors. Biochemistry 20020122
Floating-bioadhesive microspheres containing acetohydroxamic acid for clearance of Helicobacter pylori. Drug delivery 20020101
Magnetic, spectroscopic, and structural studies of dicobalt hydroxamates and model hydrolases. Inorganic chemistry 20011105
Marked reduction of Helicobacter pylori-induced gastritis by urease inhibitors, acetohydroxamic acid and flurofamide, in Mongolian gerbils. Biochemical and biophysical research communications 20010720
Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition. Bioorganic & medicinal chemistry letters 20010604
Supramolecular assembly and acid resistance of Helicobacter pylori urease. Nature structural biology 20010601
Structure-based computational study of the catalytic and inhibition mechanisms of urease. Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20010301
Interaction between iron(II) and hydroxamic acids: oxidation of iron(II) to iron(III) by desferrioxamine B under anaerobic conditions. Journal of inorganic biochemistry 20010115
Synergistic binding of ligands to angiotensin-converting enzyme. The Journal of biological chemistry 19880325
N-hydroxy-2-acetylaminofluorene as effective inhibitor of aldehyde oxidase. Biochemical and biophysical research communications 19860716
Microsome- and hepatocyte-mediated mutagenicity of hydroxyurea and related aliphatic hydroxamic acids in V79 Chinese hamster cells. Mutation research 19850101
Inhibition of urease by miscellaneous ions and compounds. Implications for the therapy of infection-induced urolithiasis. Investigative urology 19770901

Related Products

© 2019 Angene International Limited. All rights Reserved.